新经济思想研究所：生物制药创新：公平全球健康的公司治理（英文版）

Every year, millions of preventable deaths in the Global South could be averted with timely access to affordable medicines. While achieving equitable pharmaceutical access is widely recognized as a critical global health challenge, the mechanisms for doing so remain contested. Prevailing debates focus narrowly on reconciling R&D incentives with access, overlooking deeper structural and political determinants. This paper argues that the misalignment between innovation incentives and public